KYMERA THERAPEUTICS INC's ticker is KYMR and the CUSIP is 501575104. A total of 103 filers reported holding KYMERA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $67,044,274 | -39.5% | 4,823,329 | +0.0% | 0.01% | -38.1% |
| Q2 2023 | $110,873,482 | -12.8% | 4,822,683 | +12.4% | 0.02% | -16.0% |
| Q1 2023 | $127,142,862 | +11.0% | 4,291,018 | -6.5% | 0.02% | +8.7% |
| Q4 2022 | $114,593,583 | +54.3% | 4,591,089 | +34.6% | 0.02% | +43.8% |
| Q3 2022 | $74,245,000 | -25.1% | 3,410,386 | -32.3% | 0.02% | -20.0% |
| Q2 2022 | $99,137,000 | -27.4% | 5,034,940 | +56.1% | 0.02% | -13.0% |
| Q1 2022 | $136,514,000 | -20.2% | 3,225,749 | +19.7% | 0.02% | -14.8% |
| Q4 2021 | $171,093,000 | +18.0% | 2,694,814 | +9.2% | 0.03% | +8.0% |
| Q3 2021 | $144,966,000 | +261.0% | 2,467,935 | +198.1% | 0.02% | +257.1% |
| Q2 2021 | $40,155,000 | +54.4% | 827,941 | +23.7% | 0.01% | +40.0% |
| Q1 2021 | $26,009,000 | -75.0% | 669,293 | -60.4% | 0.01% | -73.7% |
| Q4 2020 | $104,050,000 | +86.4% | 1,690,579 | -4.2% | 0.02% | +58.3% |
| Q3 2020 | $55,821,000 | – | 1,764,184 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 5,858,262 | $173,580,303 | 23.50% |
| Aquilo Capital Management, LLC | 601,325 | $17,817,260 | 7.38% |
| BVF INC/IL | 4,739,004 | $140,416,689 | 5.13% |
| Artal Group S.A. | 1,805,346 | $53,492 | 3.18% |
| Redmile Group, LLC | 2,410,769 | $71,431,085 | 3.10% |
| Avoro Capital Advisors LLC | 3,855,000 | $114,223,650 | 1.69% |
| Deer Management Co. LLC | 615,895 | $18,248,969 | 1.67% |
| AtonRa Partners | 23,779 | $704,572 | 1.03% |
| Rock Springs Capital Management LP | 1,228,379 | $36,396,870 | 0.87% |
| EcoR1 Capital, LLC | 796,093 | $23,588,236 | 0.76% |